الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

janssen-cilag international nv - fentanylhydrochlorid - smerte, postoperative - analgetika - håndtering af akutte moderat til svær post-operative smerter til brug på et hospital indstilling kun.

الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - atogepant - migræneforstyrrelser - aquipta is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.

الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

vertex pharmaceuticals (ireland) limited - lumacaftor, ivacaftor - cystisk fibrose - andet respirationssystem produkter - orkambi tabletter er indiceret til behandling af cystisk fibrose (cf) hos patienter i alderen 6 år og ældre, der er homozygot for f508del-mutation i cftr-genet. orkambi granules are indicated for the treatment of cystic fibrosis (cf) in children aged 1 year and older who are homozygous for the f508del mutation in the cftr gene.

الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibakterielle midler til systemisk brug, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler..

الدانمرك - الدانماركية - Lægemiddelstyrelsen (Danish Medicines Agency)

chemische fabrik kreussler & co. - lauromacrogol 400 - injektionsvæske, opløsning - 5 mg/ml

الدانمرك - الدانماركية - Lægemiddelstyrelsen (Danish Medicines Agency)

csl behring gmbh - c1-esterase inhibitor, human - pulver og solvens til injektions- /infusionsvæske, opløsning - 500 ie

الدانمرك - الدانماركية - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - c1-esterase inhibitor, human - pulver og solvens til injektions- /infusionsvæske, opløsning - 500 ie

الدانمرك - الدانماركية - Lægemiddelstyrelsen (Danish Medicines Agency)

csl behring gmbh - c1-esterase inhibitor, human - pulver og solvens til injektionsvæske, opløsning - 1500 ie

الدانمرك - الدانماركية - Lægemiddelstyrelsen (Danish Medicines Agency)

csl behring gmbh - koagulationsfaktor xiii, humant - pulver og solvens til injektions- /infusionsvæske, opløsning - 250 ie

الدانمرك - الدانماركية - Lægemiddelstyrelsen (Danish Medicines Agency)

ever neuro pharma gmbh - apomorphinhydrochlorid hemihydrat - infusionsvæske, opløsning - 5 mg/ml